Cargando…
SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758717/ https://www.ncbi.nlm.nih.gov/pubmed/33392518 http://dx.doi.org/10.1016/S2665-9913(20)30359-3 |
| _version_ | 1783626994698682368 |
|---|---|
| author | Teng, Jialin Dai, Jin |
| author_facet | Teng, Jialin Dai, Jin |
| author_sort | Teng, Jialin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7758717 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77587172020-12-28 SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply Teng, Jialin Dai, Jin Lancet Rheumatol Correspondence Elsevier Ltd. 2021-01 2020-12-24 /pmc/articles/PMC7758717/ /pubmed/33392518 http://dx.doi.org/10.1016/S2665-9913(20)30359-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Teng, Jialin Dai, Jin SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply |
| title | SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply |
| title_full | SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply |
| title_fullStr | SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply |
| title_full_unstemmed | SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply |
| title_short | SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply |
| title_sort | sars-cov-2 serological cross-reactivity with autoantibodies – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758717/ https://www.ncbi.nlm.nih.gov/pubmed/33392518 http://dx.doi.org/10.1016/S2665-9913(20)30359-3 |
| work_keys_str_mv | AT tengjialin sarscov2serologicalcrossreactivitywithautoantibodiesauthorsreply AT daijin sarscov2serologicalcrossreactivitywithautoantibodiesauthorsreply |